Recognition underscores Miltenyi Biotec’s commitment to sustainability, complemented by strong EcoVadis performance and submission of near-term and long-term net-zero climate targets to the Science-...
Read moreBiopharmaceutical company Oniria Therapeutics, Vall d’Hebron Institute of Oncology (VHIO) and Institut Català d’Investigació Química (ICIQ) will work together on the regulatory preclinical phas...
Read moreA CNIC study reveals that neutrophils—a type of immune cell—are less aggressive at night, explaining why nighttime heart attacks are less severe than those occurring during the day
Read moreUn estudio liderado por la Universidad Rovira i Virgili ha seguido durante seis años a más de mil personas con sobrepeso u obesidad y otros indicadores metabólicos, como la hipertensión o niveles ...
Read moreEl Cancer Center Clínica Universidad de Navarra ha reunido a expertos nacionales en la II Jornada de Inmunoterapia del Cáncer Hepático para analizar los avances más prometedores en vacunas, terapi...
Read moreThis discovery reveals that the way DNA twists or 'supercoils' is key for cells to respond to oestrogens.
Read moreA research team led by Dr. Àlex Bayés, Head of the Molecular Physiology of the Synapse Group at the Institut de Recerca Sant Pau (IR Sant Pau), has achieved what for decades had been an elusive goal...
Read moreInvestigadores del CNB-CSIC han descubierto que los niveles de colesterol en la membrana celular afectan a la capacidad de las células inmunitarias para migrar a los tejidos donde son necesarias
Read moreEs la segunda vez en Europa que se detecta y describe el mecanismo de resistencia DIM-1, que inutiliza la mayoría de los antibióticos de la familia de los beta-lactámicos, lo que limita las opcione...
Read moreTaking advantage of advancements in business intelligence, clinical research has transitioned from manual data processing to sophisticated AI-driven analytics, bridging the gap between clinical and bu...
Read moreIntegrating liver health within the NCD agenda could accelerate progress and reduce inequities
Read moreThe results confirm that combining durvalumab with FLOT (fluorouracilo, leucovorina, oxaliplatina y docetaxel) is not only effective but also safe for patients.
Read more